バソプレシンの世界市場レポート 2025年

バソプレシン市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR14.4％で27億1,000万米ドルに成長します。予測期間の成長は、糖尿病性不育症の有病率の増加、薬物送達システムの改善、知識と診断の強化、研究開発イニシアティブ、糖尿病に対する意識の高まりに起因すると考えられます。予測期間における主な動向には、製造における技術開発、製剤および送達技術における革新、多剤併用治療のための個別化アプローチ、新しい治療アプローチ、健康とウェルネスへの注力、個別化およびカスタマイズなどが含まれます。

糖尿病の有病率の増加は、今後数年間のバソプレシン市場の成長を促進すると予想されます。糖尿病は、血糖値が高いことを特徴とする慢性疾患で、体内でインスリンを生成したり、効果的に使用したりすることができないことが原因です。糖尿病患者の増加は、肥満率の増加、精神衛生上の問題、ストレス、遺伝的素因などの要因に関連しています。バソプレシンは、正常な水分バランスの回復を助け、過度の喉の渇きや排尿などの症状を緩和することにより、中枢性糖尿病性不定愁訴の管理に重要な役割を果たしています。例えば、2024年6月、英国の政府機関である国民保健サービス（NHS）は、40歳未満の糖尿病患者数が2022年の17万3,166人から2023年には21万6,440人に増加したと報告し、若年層における糖尿病の有病率が大幅に上昇していることを示しています。その結果、糖尿病患者数の増加がバソプレシンの需要を牽引しています。

バソプレシン市場の主要企業は、利便性と患者の安全性を高めるため、プレミックス式すぐに使える（RTU）注射ボトルなどの革新的な製品を開発しています。これらのRTUボトルは、正確な投与量を確保しながら、調製ミスや汚染リスクを軽減します。例えば、Endo International plcは2022年2月に、すぐに使える100mLプレミックスボトルのVASOSTRICT（バソプレシン注射剤、USP）を発売しました。この種の製剤としては初めてで、在庫管理が改善され、保存可能期間は2年間、室温では最長12カ月です。mLあたり20単位を含む単回投与用バイアル、または10mLあたり200単位を含む多回投与用バイアルで、静脈内投与用の透明な溶液として供給されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界バソプレシンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のバソプレシン市場：成長率分析
• 世界のバソプレシン市場の実績：規模と成長, 2019-2024
• 世界のバソプレシン市場の予測：規模と成長, 2024-2029, 2034F
• 世界バソプレシン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のバソプレシン市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 静脈注射
• 筋肉内注射
• 皮下注射
• 世界のバソプレシン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗利尿ホルモン欠乏症
• 血管拡張性ショック
• 消化管出血
• 心室頻拍および心室細動
• 世界のバソプレシン市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• その他のエンドユーザー
• 世界のバソプレシン市場静脈注射の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標準IVバソプレシン注射
• 高用量静脈注射バソプレシン
• 敗血症およびショック治療のためのIVバソプレシン
• Ivバソプレシン術後ケア
• 世界のバソプレシン市場筋肉内注射の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標準Imバソプレシンインジェクション
• 筋肉内バソプレシンホルモンの不均衡に対する
• バソプレシン急性出血抑制のための注射
• 世界のバソプレシン市場皮下注射の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 皮下投与バソプレシン尿崩症の場合
• バソプレシン体液貯留治療のための注射
• 長時間作用型皮下製剤

第7章 地域別・国別分析

• 世界のバソプレシン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のバソプレシン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バソプレシン市場：競合情勢
• バソプレシン市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Aurobindo Pharma Limited Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Dr. Reddys Laboratories Ltd.
• Apotex Inc.
• Amneal Pharmaceuticals Inc.
• Endo Pharmaceuticals Inc.
• Mallinckrodt Pharmaceuticals Inc.
• Ferring Pharmaceuticals
• Amphastar Pharmaceuticals Inc.
• Bachem Holding AG
• Eagle Pharmaceuticals Inc.
• Par Pharmaceutical Holdings Inc.
• Athenex Inc.
• Soho-Yiming Pharmaceuticals Co. Ltd.
• Nordic Pharma Inc.
• Cumberland Pharmaceuticals Inc.
• Laboratorio ELEA S.A.C.I.F. y A.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• バソプレシン市場2029：新たな機会を提供する国
• バソプレシン市場2029：新たな機会を提供するセグメント
• バソプレシン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Vasopressin, also referred to as antidiuretic hormone (ADH), is a peptide hormone produced by the hypothalamus and secreted by the posterior pituitary gland into the bloodstream. It plays a pivotal role in regulating the body's water balance, blood pressure, and response to stress.

The primary product types of vasopressin include intravenous injection, intramuscular injection, and subcutaneous injection. Intravenous injection involves delivering the hormone directly into the bloodstream. These formulations find application in various medical conditions such as anti-diuretic hormone deficiency, vasodilatory shock, gastrointestinal bleeding, ventricular tachycardia and fibrillation, and are utilized by a range of end-users including hospitals, clinics, and other medical facilities.

The vasopressin market research report is one of a series of new reports from The Business Research Company that provides vasopressin market statistics, including vasopressin industry global market size, regional shares, competitors with a vasopressin market share, detailed vasopressin market segments, market trends, and opportunities, and any further data you may need to thrive in the vasopressin industry. This vasopressin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vasopressin market size has grown rapidly in recent years. It will grow from $1.38 billion in 2024 to $1.58 billion in 2025 at a compound annual growth rate (CAGR) of 14.7%. The growth in the historic period can be attributed to increased senior population, hospital and healthcare infrastructure development, increased prevalence of autonomic dysreflexia, increased consciousness among medical professionals, and high prevalence of chronic diseases.

The vasopressin market size is expected to see rapid growth in the next few years. It will grow to $2.71 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to growing prevalence of diabetes insipidus, improvements in medication delivery systems, enhanced knowledge and diagnosis, research and development initiatives, and increasing awareness about diabetes. Major trends in the forecast period include technological developments in manufacturing, innovations in formulations and delivery techniques, personalized approach for multimodal treatment is new therapeutic approach, focus on health and wellness, and personalization and customization.

The increasing prevalence of diabetes is expected to drive the growth of the vasopressin market in the coming years. Diabetes is a chronic condition characterized by high blood sugar levels, caused by the body's inability to produce or effectively use insulin. The rise in diabetes cases is linked to factors such as increasing obesity rates, mental health issues, stress, and genetic predisposition. Vasopressin plays a critical role in managing central diabetes insipidus by helping to restore normal water balance and alleviating symptoms like excessive thirst and urination. For example, in June 2024, the National Health Service (NHS), a UK-based government department, reported that the number of diabetes cases among individuals under 40 grew from 173,166 in 2022 to 216,440 in 2023, indicating a significant rise in the prevalence of diabetes in younger populations. As a result, the growing number of diabetes cases is driving the demand for vasopressin.

Innovative products such as pre-mix ready-to-use (RTU) injection bottles are being developed by major companies in the vasopressin market to enhance convenience and patient safety. These RTU bottles mitigate preparation errors and contamination risks while ensuring precise dosing. For example, Endo International plc introduced VASOSTRICT (vasopressin injection, USP) in ready-to-use 100 mL pre-mix bottles in February 2022. This formulation, the first of its kind, offers improved inventory management and a two-year shelf life, with up to 12 months at room temperature. It is supplied as a clear solution for intravenous administration in single-dose vials containing 20 units per mL or multiple-dose vials containing 200 units per 10 mL.

In May 2022, Fresenius Kabi acquired Ivenix Inc. for $240 million to strengthen its position in the U.S. market with an advanced infusion therapy platform. Ivenix Inc., a medical technology company specializing in infusion therapy solutions, offers vasopressin injection, further expanding Fresenius Kabi's portfolio and hospital connectivity.

Major companies operating in the vasopressin market are Pfizer Inc., Merck KGaA, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Limited, Dr. Reddys Laboratories Ltd., Apotex Inc., Amneal Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals Inc., Ferring Pharmaceuticals, Amphastar Pharmaceuticals Inc., Bachem Holding AG, Eagle Pharmaceuticals Inc., Par Pharmaceutical Holdings Inc., Athenex Inc., Soho-Yiming Pharmaceuticals Co. Ltd., Nordic Pharma Inc., Cumberland Pharmaceuticals Inc., Laboratorio ELEA S.A.C.I.F. y A., Fresenius Kabi Canada Ltd., AMOMED Pharma GmbH, BCN Peptides SA, Hainan Zhonghe Pharmaceutical Co. Ltd., Denovo Biopharma LLC

North America was the largest region in the vasopressin market in 2024. The regions covered in the vasopressin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vasopressin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vasopressin market consists of sales of arginine vasopressin (AVP), vasopressin receptor, oral tablets, sublingual tablets, nasal sprays, and oil-repository material. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vasopressin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vasopressin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vasopressin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vasopressin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Intravenous Injection; Intramuscular Injection; Subcutaneous Injection
• 2) By Application: Anti-Diuretic Hormone Deficiency; Vasodilatory Shock; Gastrointestinal Bleeding; Ventricular Tachycardia And Fibrillation
• 3) By End-User: Hospitals; Clinics; Other End Users
• Subsegments:
• 1) By Intravenous Injection: Standard Iv Vasopressin Injection; High-Dose Iv Vasopressin Injection; Iv Vasopressin For Sepsis And Shock Treatment; Iv Vasopressin For Post-Operative Care
• 2) By Intramuscular Injection: Standard Im Vasopressin Injection; Intramuscular Vasopressin For Hormonal Imbalance; Vasopressin Injection For Acute Hemorrhage Control
• 3) By Subcutaneous Injection: Subcutaneous Vasopressin For Diabetes Insipidus; Vasopressin Injection For Fluid Retention Treatment; Long-Acting Subcutaneous Vasopressin Formulations
• Companies Mentioned: Pfizer Inc.; Merck KGaA; Baxter International Inc.; Otsuka Pharmaceutical Co. Ltd.; Aurobindo Pharma Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vasopressin Market Characteristics

3. Vasopressin Market Trends And Strategies

4. Vasopressin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Vasopressin Growth Analysis And Strategic Analysis Framework

• 5.1. Global Vasopressin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Vasopressin Market Growth Rate Analysis
• 5.4. Global Vasopressin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Vasopressin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Vasopressin Total Addressable Market (TAM)

6. Vasopressin Market Segmentation

• 6.1. Global Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous Injection
• Intramuscular Injection
• Subcutaneous Injection
• 6.2. Global Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anti-Diuretic Hormone Deficiency
• Vasodilatory Shock
• Gastrointestinal Bleeding
• Ventricular Tachycardia And Fibrillation
• 6.3. Global Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Other End Users
• 6.4. Global Vasopressin Market, Sub-Segmentation Of Intravenous Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Iv Vasopressin Injection
• High-Dose Iv Vasopressin Injection
• Iv Vasopressin For Sepsis And Shock Treatment
• Iv Vasopressin For Post-Operative Care
• 6.5. Global Vasopressin Market, Sub-Segmentation Of Intramuscular Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Im Vasopressin Injection
• Intramuscular Vasopressin For Hormonal Imbalance
• Vasopressin Injection For Acute Hemorrhage Control
• 6.6. Global Vasopressin Market, Sub-Segmentation Of Subcutaneous Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Subcutaneous Vasopressin For Diabetes Insipidus
• Vasopressin Injection For Fluid Retention Treatment
• Long-Acting Subcutaneous Vasopressin Formulations

7. Vasopressin Market Regional And Country Analysis

• 7.1. Global Vasopressin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Vasopressin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vasopressin Market

• 8.1. Asia-Pacific Vasopressin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vasopressin Market

• 9.1. China Vasopressin Market Overview
• 9.2. China Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vasopressin Market

• 10.1. India Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vasopressin Market

• 11.1. Japan Vasopressin Market Overview
• 11.2. Japan Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vasopressin Market

• 12.1. Australia Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vasopressin Market

• 13.1. Indonesia Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vasopressin Market

• 14.1. South Korea Vasopressin Market Overview
• 14.2. South Korea Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vasopressin Market

• 15.1. Western Europe Vasopressin Market Overview
• 15.2. Western Europe Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vasopressin Market

• 16.1. UK Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vasopressin Market

• 17.1. Germany Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vasopressin Market

• 18.1. France Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vasopressin Market

• 19.1. Italy Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vasopressin Market

• 20.1. Spain Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vasopressin Market

• 21.1. Eastern Europe Vasopressin Market Overview
• 21.2. Eastern Europe Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vasopressin Market

• 22.1. Russia Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vasopressin Market

• 23.1. North America Vasopressin Market Overview
• 23.2. North America Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vasopressin Market

• 24.1. USA Vasopressin Market Overview
• 24.2. USA Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vasopressin Market

• 25.1. Canada Vasopressin Market Overview
• 25.2. Canada Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vasopressin Market

• 26.1. South America Vasopressin Market Overview
• 26.2. South America Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vasopressin Market

• 27.1. Brazil Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vasopressin Market

• 28.1. Middle East Vasopressin Market Overview
• 28.2. Middle East Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vasopressin Market

• 29.1. Africa Vasopressin Market Overview
• 29.2. Africa Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vasopressin Market Competitive Landscape And Company Profiles

• 30.1. Vasopressin Market Competitive Landscape
• 30.2. Vasopressin Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Aurobindo Pharma Limited Overview, Products and Services, Strategy and Financial Analysis

31. Vasopressin Market Other Major And Innovative Companies

• 31.1. Dr. Reddys Laboratories Ltd.
• 31.2. Apotex Inc.
• 31.3. Amneal Pharmaceuticals Inc.
• 31.4. Endo Pharmaceuticals Inc.
• 31.5. Mallinckrodt Pharmaceuticals Inc.
• 31.6. Ferring Pharmaceuticals
• 31.7. Amphastar Pharmaceuticals Inc.
• 31.8. Bachem Holding AG
• 31.9. Eagle Pharmaceuticals Inc.
• 31.10. Par Pharmaceutical Holdings Inc.
• 31.11. Athenex Inc.
• 31.12. Soho-Yiming Pharmaceuticals Co. Ltd.
• 31.13. Nordic Pharma Inc.
• 31.14. Cumberland Pharmaceuticals Inc.
• 31.15. Laboratorio ELEA S.A.C.I.F. y A.

32. Global Vasopressin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vasopressin Market

34. Recent Developments In The Vasopressin Market

35. Vasopressin Market High Potential Countries, Segments and Strategies

• 35.1 Vasopressin Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Vasopressin Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Vasopressin Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer